Terms ending in 2028
Every in-force patent on The Institut Pasteur's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,174,105 | Use of VHH Antibodies for the Preparation of Peptide Vectors for Delivering a Substance of Interest and Their Applications In force · Medium confidence | Centre National de la Recherche Scientifique (CNRS) | In force | Medium confidence | |
| US 8,003,773 | Polynucleotides Encoding MHC Class I-Restricted Htert Epitopes, Analogues Thereof or Polyepitopes In force · High confidence | Institut Pasteur | In force | High confidence | |
| US 9,624,479 | Polynucleotides Encoding MHC Class I-Restricted Htert Epitopes, Analogues Thereof or Polyepitopes In force · High confidence | Inserm (Institut National de la Sante et de la Recherche Medicale) | In force | High confidence | |
| US 9,636,395 | Medicaments and Methods for Treating Mesothelioma In force · Medium confidence | Centre National de la Recherche Scientifique | In force | Medium confidence | |
| US 9,056,071 | Compounds and Methods for Preventing or Treating a Viral Infection In force · High confidence | Astremiha Therapeutics | In force | High confidence | |
| US 9,833,492 | Combinations of a Caspase Inhibitor and an Antiviral Agent In force · High confidence | Astremiha Therapeutics | In force | High confidence | |
| US 9,328,146 | Lentiviral Gene Transfer Vectors and Their Medicinal Applications In force · Low confidence | Centre National de la Recherche Scientifique | In force | Low confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by The Institut Pasteur.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.